fda glp-1 compounding enforcement news october 2025 Ozempic's patent problem: how Novo Nordisk lost control of a blockbuster drug. 💉 Demand for weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite FDA is moving to restrict

Recent data has also confirmed that when patients stop treatment they regain lost weight. Using AI to identify Ozempic-like plant extracts Murcia and her colleagues used high-performance AI techniques to identify non-peptide natural compounds that can activate the GLP-1 receptor

Unlike mass-produced medications, compounded semaglutide allows for personalized dosing that starts low and increases gradually as your body adapts

But the experts say its a good idea for people who struggle to get enough via diet alone to supplement with protein powders or premade shakes

Lingampelly SS, Naviaux JC, Heuer LS, Monk JM, Li K, Wang L, et al

Batch 5666 tested at 98.82% purity by independent HPLC at Testides Analytical

What the Research Shows Tirzepatide's Metabolic Correction Potential Tirzepatide produces the most strong metabolic improvements of any available medication